Inventor · disambiguated record
Isabel Kalofonos
Also filed as: KALOFONOS ISABEL
6 granted patents·7 pending applications·1 citations·filing 2009–2017
70Inventor score
Technology areasA61P
Top patents by PatentIndex Score
13 records- 0171US8906948B2Choline cocrystal of epalrestatKALOFONOS ISABEL·Filed 2009·Granted Dec 9, 2014·1 cites·20 claims
- 0256US9611234B2Choline cocrystal of epalrestatBIONEVIA LLC·Filed 2014·Granted Apr 4, 2017·0 cites·10 claims
- 0353US10464912B2Choline cocrystal of epalrestatBIONEVIA PHARMACEUTICALS INC·Filed 2017·Granted Nov 5, 2019·0 cites·16 claims
- 0452US9447056B2Solid forms of epalrestatBIONEVIA PHARMACEUTICALS INC·Filed 2014·Granted Sep 20, 2016·0 cites·6 claims
- 0550US8697735B2Solid forms of epalrestatKALOFONOS ISABEL·Filed 2011·Granted Apr 15, 2014·0 cites·21 claims
- 0648US2011281911A1Novel forms of eperisoneKALOFONOS ISABEL·Filed 2009·Application pending·0 cites
- 0747US9566269B2Modified release compositions of epalrestat or a derivative thereof and methods for using the sameKALOFONOS ISABEL·Filed 2012·Granted Feb 14, 2017·0 cites·21 claims
- 0846US2010069389A1Novel forms of reboxetineBIONEVIA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0945US2011275695A1Crystalline forms of zotepine hydrochlorideBIONEVIA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1045US2011275679A1Flupirtine hydrochloride maleic acid cocrystalBIONEVIA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1138US2018000792A1Modified release compositions of epalrestat or a derivative thereof and methods for using the sameBIONEVIA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1231US2012196895A1Novel forms of eperisoneKALOFONOS ISABEL·Filed 2010·Application pending·0 cites
- 1330US2012028930A1Flupirtine salts and polymorphsKALOFONOS ISABEL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Isabel Kalofonos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →